The Omicron Follies: Covid-19 Variant Names Offer a Lesson in Bad Branding
Rebecca Deczynski of INC. contacted me recently to ask for my opinion on the naming of Covid-19 variants. Here’s what I had to say. To effectively market anything – product …
The Importance of Process with Laurel Sutton of Catchword
I was invited to appear on the excellent Journey Map podcast, where I spoke with Dave Hale about the steep learning curve in the naming industry, the importance of process, …
Why ‘Fort Liberty’? Leaders explain why they pushed for Fort Bragg’s proposed new name
Jay Price of North Carolina Public Radio contacted me recently to ask for my opinion on the renaming of army bases. Here’s what I had to say. When a federal …
Branding: Can companies reposition themselves by changing their image?
Susan Ladika of CQ Researcher contacted me recently to ask for my opinion on rebranding: Will a rebranding change a company’s reputation? CQ publishes a pro/con debate written by outside …
What happened to all the ‘good’ drug names? Inside the modern day dilemma of Rx naming
I was interviewed by Beth Snyder Bulik, Senior Editor at EndpointsNews for this piece about drug names. Prescription drug names often spark speculation, debates and sometimes derision, but they also …
The expert’s view – Facebook’s move to Meta
I was interviewed by Transform for this piece about Facebook’s name change. At the annual Facebook Connect conference, founder and CEO Mark Zuckerberg announced Facebook group’s official rebrand to Meta, …
Renaming the company won’t fix Facebook’s image problem
I was interviewed by Popular Science for this piece about Facebook’s name change. This week, news dropped that Facebook may be following the tried and true playbook of other tech …
A New Name Won’t Fix Facebook
I was interviewed by Time Magazine for this piece about Facebook’s name change. The article can also be read here. When an established company becomes fraught with scandal, advisers will …
Comirnaty: Why the president of the American Naming Society isn’t exactly a fan of the name
Phoebe Bain interviewed me for this piece on the name of Pfizer’s Covid vaccine, originally appearing at Morningbrew She prefers Covuity, which was also in the running for Pfizer’s Covid …
The art of the rename: How brands decide what to call themselves next
Phoebe Bain interviewed me for this piece on renaming, originally appearing at Morningbrew What considerations go into choosing a new moniker? From football teams to pancake mixes, a lot of …